{{Rsnum
|rsid=11886868
|Gene=BCL11A
|Chromosome=2
|position=60493111
|Orientation=plus
|GMAF=0.4963
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=BCL11A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 42.5 | 48.7
| HCB | 91.2 | 8.8 | 0.0
| JPT | 93.8 | 6.2 | 0.0
| YRI | 2.7 | 40.8 | 56.5
| ASW | 5.3 | 33.3 | 61.4
| CHB | 91.2 | 8.8 | 0.0
| CHD | 96.3 | 3.7 | 0.0
| GIH | 28.7 | 54.5 | 16.8
| LWK | 12.7 | 37.3 | 50.0
| MEX | 32.8 | 53.4 | 13.8
| MKK | 18.6 | 47.4 | 34.0
| TSI | 8.8 | 42.2 | 49.0
| HapMapRevision=28
}}{{omim
|desc=FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5
|id=142335
|rsnum=11886868
}}

{{omim
|desc=SICKLE CELL ANEMIA
|id=603903
|rsnum=11886868
}}

{{omim
|desc=HEMOGLOBIN--BETA LOCUS; HBB
|id=141900
|rsnum=11886868
}}

{{PMID Auto
|PMID=20472475
|Title=The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients
}}
{{PMID Auto GWAS
|PMID=18245381
|Trait=Fetal hemoglobin levels
|Title=Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
|RiskAllele=T
|Pval=7E-35
|OR=0.48
|ORtxt=[NR] s.d. decrease in HbF
|OA=1
}}

{{PMID Auto
|PMID=18667698
|Title=DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
|OA=1
}}

{{PMID Auto
|PMID=20401335
|Title=Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}